脳神経外科に関する市場調査。脳神経外科用インターベンションデバイスの需要は最も高い水準で推移Market Study on Neurosurgery: Demand to Remain Highest for Neuro-interventional Devices 脳神経外科市場レポート対象範囲 世界の脳神経外科市場に関するPersistence Market Researchの最新出版物は、機会と現在の市場ランドスケープを評価し、市場に影響を与える対応するセクションについての詳細な... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー脳神経外科市場レポート対象範囲世界の脳神経外科市場に関するPersistence Market Researchの最新出版物は、機会と現在の市場ランドスケープを評価し、市場に影響を与える対応するセクションについての詳細な分析と更新を提供します。この研究は、市場のドライバー、抑制、トレンド、および機会を含む現在の市場ダイナミクスに詳細な洞察を提供しています。市場調査の主な目的は、市場が2022年から2032年の予測期間中に実行される方法についての排他的な情報を提示することです。 市場の成功成長のための重要な指標は、この包括的なレポートで提示されており、市場の前年比(YoY)成長分析、複合年間成長率(CAGR)など、Persistence Market Research社の調査において網羅的に記述されています。この調査研究は、脳神経外科市場製品の需要と調査期間中の定量的な開発機会を知るために読者をサポートすることができます。 この研究は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、脳神経外科市場で繁栄するために適切なビジネス戦略を開発する際にそれらを助けることができますこのPersistence Market Researchの研究で示された洞察と情報は、脳神経外科市場の株主、業界の専門家、投資家、研究者および記者、ならびにビジネス愛好家によって活用されることができる。 市場統計だけでなく、神経外科市場のビジネスシナリオに影響を与えるマクロだけでなく、ミクロ経済変数にリンクされている情報は、現在の研究にも含まれています。市場の潜在的な開発に応じて、実質的な洞察力は、このレポートで発生します。さらに、このレポートで提出されたデータによって、マイナーな企業や業界の新規参入者は、市場での牽引力を達成するために適切な企業の選択を行う際に支援することができます。 主要な市場セグメント Persistence Market Researchの脳神経外科市場に関する調査では、製品、エンドユーザー、地域の3つの重要なセグメントに分けられた情報を提供しています。本レポートでは、これらのカテゴリに関連する重要な市場ダイナミクスと成長パラメータに関する包括的なデータと情報を提供しています。 製品 神経インターベンションデバイス 神経血管塞栓用デバイス 塞栓用コイル リキッドエンボリックシステム フローダイバージョンステント 動脈瘤クリップ 脳血管内コイリングアシスト装置 コイリングアシストステント コイリングアシストバルーン 血管内血栓除去装置 ステントリトリーバー 吸引式リトリーバー マイクロガイドワイヤー マイクロカテーテル サポートカテーテル 頭蓋内ステント 神経内視鏡 軟性神経内視鏡 硬性神経内視鏡 脳外科用ドリル 空気圧式脳外科手術用ドリル 電気式脳外科手術用ドリル 放射線手術装置 リニアアクセラレータ放射線手術システム ガンマナイフ放射線手術システム 硬膜代替物 生体硬膜代替物 合成硬膜代替物 脳神経外科用アブレーションデバイス MRIガイド下集束超音波装置 MRIガイド下レーザー治療装置 MRIガイド下RFアブレーションシステム 脳神経外科手術用器具 ティッシュリトラクター 鉗子 ヘッドフレーム 頚椎固定装置 パーフォレーター エンドユーザー 病院 外来外科センター 神経系専門施設 地域別 北アメリカ ラテンアメリカ 欧州 東アジア 南アジア オセアニア 中東・アフリカ 報告書に記載されている主な質問 今後数年間、脳神経外科の最も収益性の高い市場として存続し続けるのはどの地域か? トレンドの変化は市場にどのような影響を与えるか? COVID-19危機は市場の成長にどのような影響を及ぼしたか? 市場参加者はどのようにして先進地域の低空飛行の機会を捉えることができるのか? 市場におけるステークホルダーの戦略はどのようなものですか? 投資家が認識する必要があり、市場への投資中に取り組む可能性がある抑制要因は何か? 市場に影響を与える開発動向は何か? 脳神経外科市場の企業は、どのようにして先進国および新興国の成長機会を利用することができるのか? 調査方法 Persistence Market Research社の調査では、神経外科市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論に到達するために、独自の調査手法が利用されている。この調査手法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立つものである。 市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、ホワイトペーパー、社内外の独自データベースなどがあります。アナリストは一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、神経外科市場の成長見通しに関するPersistence Market Researchの予測をより正確かつ信頼性の高いものにしています。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions & Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Key Disease Epidemiology 4.2. Product Adoption / Usage Analysis 4.3. Product USPs / Features 4.4. Key Promotional Strategies, By Manufacturers 4.5. Porter’s Analysis 4.6. PESTLE Analysis 4.7. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Market GDP and Growth Outlook 5.1.2. Global Assistive Devices Market Overview 5.1.3. Medical Device Industry Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. GDP Growth Forecast 5.2.2. Ageing Population 5.2.3. Growing Prevalence of Neurologic Diseases 5.2.4. Growing Healthcare Expenditure 5.2.5. Shift Towards Minimally Invasive Procedures 5.2.6. Growing Research Efforts 5.2.7. Cost Impact 5.2.8. Entries Of New Start-Up Companies In The Market 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. Revenue By Product 6.1.2. Revenue By End User 6.1.3. Revenue by Country 6.2. 2021 Market Scenario 7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By Product 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032 8.3.1. Neuro Interventional Devices 8.3.1.1. Neurovascular Embolization Devices 8.3.1.1.1. Embolization Coils 8.3.1.1.2. Liquid Embolic Systems 8.3.1.1.3. Flow Diversion Stents 8.3.1.1.4. Aneurysm Clips 8.3.1.2. Neurovascular Coiling Assist Devices 8.3.1.2.1. Coiling Assist Stents 8.3.1.2.2. Coiling Assist Balloons 8.3.1.3. Neurovascular Thrombectomy Devices 8.3.1.3.1. Stent Retrievers 8.3.1.3.2. Aspiration Retrievers 8.3.1.4. Microguidewires 8.3.1.5. Microcatheters 8.3.1.6. Support Catheters 8.3.1.7. Intracranial Stents 8.3.2. Neuroendoscopes 8.3.2.1. Flexible Neuroendoscopes 8.3.2.2. Rigid Neuroendoscopes 8.3.3. Neurosurgical Drills 8.3.3.1. Pneumatic Neurosurgical Drills 8.3.3.2. Electrical Neurosurgical Drills 8.3.4. Radiosurgery Systems 8.3.4.1. Linear Accelerator Radiosurgery Systems 8.3.4.2. Gamma Knife Radiosurgery Systems 8.3.5. Dura Substitutes 8.3.5.1. Biological Dura Substitutes 8.3.5.2. Synthetic Dura Substitutes 8.3.6. Neurosurgical Ablation Devices 8.3.6.1. MRI Guided Focused Ultrasound Systems 8.3.6.2. MRI Guided Laser Therapy Systems 8.3.6.3. MRI Guided RF Ablation Systems 8.3.7. Neurosurgery Instruments 8.3.7.1. Tissue Retractors 8.3.7.2. Forceps 8.3.7.3. Head Frames 8.3.7.4. Cervical Plating systems 8.3.7.5. Perforators 8.4. Market Attractiveness Analysis By Product 9. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 9.3.1. Hospitals 9.3.2. Ambulatory Surgical Centers 9.3.3. Specialized Neurological Institutes 9.4. Market Attractiveness Analysis By End User 10. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 11.3.1. By Country 11.3.1.1. U.S. 11.3.1.2. Canada 11.3.2. By Product 11.3.3. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product 11.4.3. By End User 11.5. Market Trends 11.6. Key Market Participants - Intensity Mapping 11.7. Drivers and Restraints - Impact Analysis 11.8. Country Level Analysis & Forecast 11.8.1. U.S. Neurosurgery Market 11.8.1.1. Introduction 11.8.1.2. Market Analysis and Forecast by Market Taxonomy 11.8.1.2.1. By Product 11.8.1.2.2. By End User 11.8.2. Canada Neurosurgery Market 11.8.2.1. Introduction 11.8.2.2. Market Analysis and Forecast by Market Taxonomy 11.8.2.2.1. By Product 11.8.2.2.2. By End User 12. Latin America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Argentina 12.3.1.3. Mexico 12.3.1.4. Rest of Latin America 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Market Trends 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 12.8. Country Level Analysis & Forecast 12.8.1. Brazil Neurosurgery Market 12.8.1.1. Introduction 12.8.1.2. Market Analysis and Forecast by Market Taxonomy 12.8.1.2.1. By Product 12.8.1.2.2. By End User 12.8.2. Mexico Neurosurgery Market 12.8.2.1. Introduction 12.8.2.2. Market Analysis and Forecast by Market Taxonomy 12.8.2.2.1. By Product 12.8.2.2.2. By End User 12.8.3. Argentina Neurosurgery Market 12.8.3.1. Introduction 12.8.3.2. Market Analysis and Forecast by Market Taxonomy 12.8.3.2.1. By Product 12.8.3.2.2. By End User 13. Europe Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. France 13.3.1.3. Italy 13.3.1.4. Spain 13.3.1.5. UK 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Nordic Countries 13.3.1.9. Rest of Europe 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis & Forecast 13.8.1. Germany Neurosurgery Market 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By End User 13.8.2. Italy Neurosurgery Market 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By End User 13.8.3. France Neurosurgery Market 13.8.3.1. Introduction 13.8.3.2. Market Analysis and Forecast by Market Taxonomy 13.8.3.2.1. By Product 13.8.3.2.2. By End User 13.8.3.2.3. 13.8.4. Spain Neurosurgery Market 13.8.4.1. Introduction 13.8.4.2. Market Analysis and Forecast by Market Taxonomy 13.8.4.2.1. By Product 13.8.4.2.2. By End User 13.8.5. U.K. Neurosurgery Market 13.8.5.1. Introduction 13.8.5.2. Market Analysis and Forecast by Market Taxonomy 13.8.5.2.1. By Product 13.8.5.2.2. By End User 13.8.6. Benelux Union Neurosurgery Market 13.8.6.1. Introduction 13.8.6.2. Market Analysis and Forecast by Market Taxonomy 13.8.6.2.1. By Product 13.8.6.2.2. By End User 13.8.7. Nordic Countries Neurosurgery Market 13.8.7.1. Introduction 13.8.7.2. Market Analysis and Forecast by Market Taxonomy 13.8.7.2.1. By Product 13.8.7.2.2. By End User 13.8.8. Russia Neurosurgery Market 13.8.8.1. Introduction 13.8.8.2. Market Analysis and Forecast by Market Taxonomy 13.8.8.2.1. By Product 13.8.8.2.2. By End User 14. South Asia and Pacific Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Indonesia 14.3.1.3. Malaysia 14.3.1.4. Thailand 14.3.1.5. Rest of South Asia 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. India Neurosurgery Market 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By End User 14.8.2. Indonesia Neurosurgery Market 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By End User 14.8.3. Malaysia Neurosurgery Market 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By End User 14.8.4. Thailand Neurosurgery Market 14.8.4.1. Introduction 14.8.4.2. Market Analysis and Forecast by Market Taxonomy 14.8.4.2.1. By Product 14.8.4.2.2. By End User 15. East Asia Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. China Neurosurgery Market 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By End User 15.8.2. Japan Neurosurgery Market 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By End User 15.8.3. South Korea Neurosurgery Market 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By End User 16. Oceania Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. Australia Neurosurgery Market 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By End User 16.8.2. New Zealand Neurosurgery Market 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By End User 17. Middle East and Africa Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Turkey 17.3.1.3. Israel 17.3.1.4. Northern Africa 17.3.1.5. South Africa 17.3.1.6. Rest of Middle East and Africa 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. GCC Countries Neurosurgery Market 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By End User 17.8.2. Turkey Neurosurgery Market 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By End User 17.8.3. North Africa Neurosurgery Market 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By End User 17.8.4. South Africa Neurosurgery Market 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By End User 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Share Analysis of Top Players 18.3. Market Presence Analysis 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Stryker Corp. 19.3.1.1. .Overview 19.3.1.2. Product Portfolio 19.3.1.3. Key Financials 19.3.1.4. SWOT Analysis 19.3.1.5. Key Developments 19.3.1.6. Sales Footprint 19.3.1.7. Strategy Overview 19.3.1.7.1. Marketing Strategy 19.3.1.7.2. Product Strategy 19.3.1.7.3. Channel Strategy 19.3.2. B. Braun Melsungen AG 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Key Financials 19.3.2.4. SWOT Analysis 19.3.2.5. Key Developments 19.3.2.6. Sales Footprint 19.3.2.7. Strategy Overview 19.3.2.7.1. Marketing Strategy 19.3.2.7.2. Product Strategy 19.3.2.7.3. Channel Strategy 19.3.3. Medtronic plc 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Key Financials 19.3.3.4. SWOT Analysis 19.3.3.5. Key Developments 19.3.3.6. Sales Footprint 19.3.3.7. Strategy Overview 19.3.3.7.1. Marketing Strategy 19.3.3.7.2. Product Strategy 19.3.3.7.3. Channel Strategy 19.3.4. DePuy Synthes 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Key Financials 19.3.4.4. SWOT Analysis 19.3.4.5. Key Developments 19.3.4.6. Sales Footprint 19.3.4.7. Strategy Overview 19.3.4.7.1. Marketing Strategy 19.3.4.7.2. Product Strategy 19.3.4.7.3. Channel Strategy 19.3.5. Boston Scientific 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Key Financials 19.3.5.4. SWOT Analysis 19.3.5.5. Key Developments 19.3.5.6. Sales Footprint 19.3.5.7. Strategy Overview 19.3.5.7.1. Marketing Strategy 19.3.5.7.2. Product Strategy 19.3.5.7.3. Channel Strategy 19.3.6. Terumo Corporation 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Key Financials 19.3.6.4. SWOT Analysis 19.3.6.5. Key Developments 19.3.6.6. Sales Footprint 19.3.6.7. Strategy Overview 19.3.6.7.1. Marketing Strategy 19.3.6.7.2. Product Strategy 19.3.6.7.3. Channel Strategy 19.3.7. KARL STORZ GmbH & Co KG 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Key Financials 19.3.7.4. SWOT Analysis 19.3.7.5. Key Developments 19.3.7.6. Sales Footprint 19.3.7.7. Strategy Overview 19.3.7.7.1. Marketing Strategy 19.3.7.7.2. Product Strategy 19.3.7.7.3. Channel Strategy 19.3.8. Integra LifeSciences 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Key Financials 19.3.8.4. SWOT Analysis 19.3.8.5. Key Developments 19.3.8.6. Sales Footprint 19.3.8.7. Strategy Overview 19.3.8.7.1. Marketing Strategy 19.3.8.7.2. Product Strategy 19.3.8.7.3. Channel Strategy 19.3.9. Penumbra Inc 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Key Financials 19.3.9.4. SWOT Analysis 19.3.9.5. Key Developments 19.3.9.6. Sales Footprint 19.3.9.7. Strategy Overview 19.3.9.7.1. Marketing Strategy 19.3.9.7.2. Product Strategy 19.3.9.7.3. Channel Strategy 19.3.10. Adeor Medical AG 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Key Financials 19.3.10.4. SWOT Analysis 19.3.10.5. Key Developments 19.3.10.6. Sales Footprint 19.3.10.7. Strategy Overview 19.3.10.7.1. Marketing Strategy 19.3.10.7.2. Product Strategy 19.3.10.7.3. Channel Strategy 19.3.11. Elekta 19.3.11.1. Overview 19.3.11.2. Product Portfolio 19.3.11.3. Key Financials 19.3.11.4. SWOT Analysis 19.3.11.5. Key Developments 19.3.11.6. Sales Footprint 19.3.11.7. Strategy Overview 19.3.11.7.1. Marketing Strategy 19.3.11.7.2. Product Strategy 19.3.11.7.3. Channel Strategy 19.3.12. Clarus Medical 19.3.12.1. Overview 19.3.12.2. Product Portfolio 19.3.12.3. Key Financials 19.3.12.4. SWOT Analysis 19.3.12.5. Key Developments 19.3.12.6. Sales Footprint 19.3.12.7. Strategy Overview 19.3.12.7.1. Marketing Strategy 19.3.12.7.2. Product Strategy 19.3.12.7.3. Channel Strategy 19.3.13. MACHIDA ENDOSCOPE CO., LTD. 19.3.13.1. Overview 19.3.13.2. Product Portfolio 19.3.13.3. Key Financials 19.3.13.4. SWOT Analysis 19.3.13.5. Key Developments 19.3.13.6. Sales Footprint 19.3.13.7. Strategy Overview 19.3.13.7.1. Marketing Strategy 19.3.13.7.2. Product Strategy 19.3.13.7.3. Channel Strategy 20. Assumptions and Acronyms Used 21. Research Methodology
SummaryNeurosurgery Market: Scope of Report Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions & Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Key Disease Epidemiology 4.2. Product Adoption / Usage Analysis 4.3. Product USPs / Features 4.4. Key Promotional Strategies, By Manufacturers 4.5. Porter’s Analysis 4.6. PESTLE Analysis 4.7. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Market GDP and Growth Outlook 5.1.2. Global Assistive Devices Market Overview 5.1.3. Medical Device Industry Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. GDP Growth Forecast 5.2.2. Ageing Population 5.2.3. Growing Prevalence of Neurologic Diseases 5.2.4. Growing Healthcare Expenditure 5.2.5. Shift Towards Minimally Invasive Procedures 5.2.6. Growing Research Efforts 5.2.7. Cost Impact 5.2.8. Entries Of New Start-Up Companies In The Market 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. Revenue By Product 6.1.2. Revenue By End User 6.1.3. Revenue by Country 6.2. 2021 Market Scenario 7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By Product 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032 8.3.1. Neuro Interventional Devices 8.3.1.1. Neurovascular Embolization Devices 8.3.1.1.1. Embolization Coils 8.3.1.1.2. Liquid Embolic Systems 8.3.1.1.3. Flow Diversion Stents 8.3.1.1.4. Aneurysm Clips 8.3.1.2. Neurovascular Coiling Assist Devices 8.3.1.2.1. Coiling Assist Stents 8.3.1.2.2. Coiling Assist Balloons 8.3.1.3. Neurovascular Thrombectomy Devices 8.3.1.3.1. Stent Retrievers 8.3.1.3.2. Aspiration Retrievers 8.3.1.4. Microguidewires 8.3.1.5. Microcatheters 8.3.1.6. Support Catheters 8.3.1.7. Intracranial Stents 8.3.2. Neuroendoscopes 8.3.2.1. Flexible Neuroendoscopes 8.3.2.2. Rigid Neuroendoscopes 8.3.3. Neurosurgical Drills 8.3.3.1. Pneumatic Neurosurgical Drills 8.3.3.2. Electrical Neurosurgical Drills 8.3.4. Radiosurgery Systems 8.3.4.1. Linear Accelerator Radiosurgery Systems 8.3.4.2. Gamma Knife Radiosurgery Systems 8.3.5. Dura Substitutes 8.3.5.1. Biological Dura Substitutes 8.3.5.2. Synthetic Dura Substitutes 8.3.6. Neurosurgical Ablation Devices 8.3.6.1. MRI Guided Focused Ultrasound Systems 8.3.6.2. MRI Guided Laser Therapy Systems 8.3.6.3. MRI Guided RF Ablation Systems 8.3.7. Neurosurgery Instruments 8.3.7.1. Tissue Retractors 8.3.7.2. Forceps 8.3.7.3. Head Frames 8.3.7.4. Cervical Plating systems 8.3.7.5. Perforators 8.4. Market Attractiveness Analysis By Product 9. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 9.3.1. Hospitals 9.3.2. Ambulatory Surgical Centers 9.3.3. Specialized Neurological Institutes 9.4. Market Attractiveness Analysis By End User 10. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 11.3.1. By Country 11.3.1.1. U.S. 11.3.1.2. Canada 11.3.2. By Product 11.3.3. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product 11.4.3. By End User 11.5. Market Trends 11.6. Key Market Participants - Intensity Mapping 11.7. Drivers and Restraints - Impact Analysis 11.8. Country Level Analysis & Forecast 11.8.1. U.S. Neurosurgery Market 11.8.1.1. Introduction 11.8.1.2. Market Analysis and Forecast by Market Taxonomy 11.8.1.2.1. By Product 11.8.1.2.2. By End User 11.8.2. Canada Neurosurgery Market 11.8.2.1. Introduction 11.8.2.2. Market Analysis and Forecast by Market Taxonomy 11.8.2.2.1. By Product 11.8.2.2.2. By End User 12. Latin America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Argentina 12.3.1.3. Mexico 12.3.1.4. Rest of Latin America 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Market Trends 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 12.8. Country Level Analysis & Forecast 12.8.1. Brazil Neurosurgery Market 12.8.1.1. Introduction 12.8.1.2. Market Analysis and Forecast by Market Taxonomy 12.8.1.2.1. By Product 12.8.1.2.2. By End User 12.8.2. Mexico Neurosurgery Market 12.8.2.1. Introduction 12.8.2.2. Market Analysis and Forecast by Market Taxonomy 12.8.2.2.1. By Product 12.8.2.2.2. By End User 12.8.3. Argentina Neurosurgery Market 12.8.3.1. Introduction 12.8.3.2. Market Analysis and Forecast by Market Taxonomy 12.8.3.2.1. By Product 12.8.3.2.2. By End User 13. Europe Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. France 13.3.1.3. Italy 13.3.1.4. Spain 13.3.1.5. UK 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Nordic Countries 13.3.1.9. Rest of Europe 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis & Forecast 13.8.1. Germany Neurosurgery Market 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By End User 13.8.2. Italy Neurosurgery Market 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By End User 13.8.3. France Neurosurgery Market 13.8.3.1. Introduction 13.8.3.2. Market Analysis and Forecast by Market Taxonomy 13.8.3.2.1. By Product 13.8.3.2.2. By End User 13.8.3.2.3. 13.8.4. Spain Neurosurgery Market 13.8.4.1. Introduction 13.8.4.2. Market Analysis and Forecast by Market Taxonomy 13.8.4.2.1. By Product 13.8.4.2.2. By End User 13.8.5. U.K. Neurosurgery Market 13.8.5.1. Introduction 13.8.5.2. Market Analysis and Forecast by Market Taxonomy 13.8.5.2.1. By Product 13.8.5.2.2. By End User 13.8.6. Benelux Union Neurosurgery Market 13.8.6.1. Introduction 13.8.6.2. Market Analysis and Forecast by Market Taxonomy 13.8.6.2.1. By Product 13.8.6.2.2. By End User 13.8.7. Nordic Countries Neurosurgery Market 13.8.7.1. Introduction 13.8.7.2. Market Analysis and Forecast by Market Taxonomy 13.8.7.2.1. By Product 13.8.7.2.2. By End User 13.8.8. Russia Neurosurgery Market 13.8.8.1. Introduction 13.8.8.2. Market Analysis and Forecast by Market Taxonomy 13.8.8.2.1. By Product 13.8.8.2.2. By End User 14. South Asia and Pacific Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Indonesia 14.3.1.3. Malaysia 14.3.1.4. Thailand 14.3.1.5. Rest of South Asia 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. India Neurosurgery Market 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By End User 14.8.2. Indonesia Neurosurgery Market 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By End User 14.8.3. Malaysia Neurosurgery Market 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By End User 14.8.4. Thailand Neurosurgery Market 14.8.4.1. Introduction 14.8.4.2. Market Analysis and Forecast by Market Taxonomy 14.8.4.2.1. By Product 14.8.4.2.2. By End User 15. East Asia Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. China Neurosurgery Market 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By End User 15.8.2. Japan Neurosurgery Market 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By End User 15.8.3. South Korea Neurosurgery Market 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By End User 16. Oceania Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. Australia Neurosurgery Market 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By End User 16.8.2. New Zealand Neurosurgery Market 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By End User 17. Middle East and Africa Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Turkey 17.3.1.3. Israel 17.3.1.4. Northern Africa 17.3.1.5. South Africa 17.3.1.6. Rest of Middle East and Africa 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. GCC Countries Neurosurgery Market 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By End User 17.8.2. Turkey Neurosurgery Market 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By End User 17.8.3. North Africa Neurosurgery Market 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By End User 17.8.4. South Africa Neurosurgery Market 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Product 17.8.4.2.2. By End User 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Share Analysis of Top Players 18.3. Market Presence Analysis 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Stryker Corp. 19.3.1.1. .Overview 19.3.1.2. Product Portfolio 19.3.1.3. Key Financials 19.3.1.4. SWOT Analysis 19.3.1.5. Key Developments 19.3.1.6. Sales Footprint 19.3.1.7. Strategy Overview 19.3.1.7.1. Marketing Strategy 19.3.1.7.2. Product Strategy 19.3.1.7.3. Channel Strategy 19.3.2. B. Braun Melsungen AG 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Key Financials 19.3.2.4. SWOT Analysis 19.3.2.5. Key Developments 19.3.2.6. Sales Footprint 19.3.2.7. Strategy Overview 19.3.2.7.1. Marketing Strategy 19.3.2.7.2. Product Strategy 19.3.2.7.3. Channel Strategy 19.3.3. Medtronic plc 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Key Financials 19.3.3.4. SWOT Analysis 19.3.3.5. Key Developments 19.3.3.6. Sales Footprint 19.3.3.7. Strategy Overview 19.3.3.7.1. Marketing Strategy 19.3.3.7.2. Product Strategy 19.3.3.7.3. Channel Strategy 19.3.4. DePuy Synthes 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Key Financials 19.3.4.4. SWOT Analysis 19.3.4.5. Key Developments 19.3.4.6. Sales Footprint 19.3.4.7. Strategy Overview 19.3.4.7.1. Marketing Strategy 19.3.4.7.2. Product Strategy 19.3.4.7.3. Channel Strategy 19.3.5. Boston Scientific 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Key Financials 19.3.5.4. SWOT Analysis 19.3.5.5. Key Developments 19.3.5.6. Sales Footprint 19.3.5.7. Strategy Overview 19.3.5.7.1. Marketing Strategy 19.3.5.7.2. Product Strategy 19.3.5.7.3. Channel Strategy 19.3.6. Terumo Corporation 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Key Financials 19.3.6.4. SWOT Analysis 19.3.6.5. Key Developments 19.3.6.6. Sales Footprint 19.3.6.7. Strategy Overview 19.3.6.7.1. Marketing Strategy 19.3.6.7.2. Product Strategy 19.3.6.7.3. Channel Strategy 19.3.7. KARL STORZ GmbH & Co KG 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Key Financials 19.3.7.4. SWOT Analysis 19.3.7.5. Key Developments 19.3.7.6. Sales Footprint 19.3.7.7. Strategy Overview 19.3.7.7.1. Marketing Strategy 19.3.7.7.2. Product Strategy 19.3.7.7.3. Channel Strategy 19.3.8. Integra LifeSciences 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Key Financials 19.3.8.4. SWOT Analysis 19.3.8.5. Key Developments 19.3.8.6. Sales Footprint 19.3.8.7. Strategy Overview 19.3.8.7.1. Marketing Strategy 19.3.8.7.2. Product Strategy 19.3.8.7.3. Channel Strategy 19.3.9. Penumbra Inc 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Key Financials 19.3.9.4. SWOT Analysis 19.3.9.5. Key Developments 19.3.9.6. Sales Footprint 19.3.9.7. Strategy Overview 19.3.9.7.1. Marketing Strategy 19.3.9.7.2. Product Strategy 19.3.9.7.3. Channel Strategy 19.3.10. Adeor Medical AG 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Key Financials 19.3.10.4. SWOT Analysis 19.3.10.5. Key Developments 19.3.10.6. Sales Footprint 19.3.10.7. Strategy Overview 19.3.10.7.1. Marketing Strategy 19.3.10.7.2. Product Strategy 19.3.10.7.3. Channel Strategy 19.3.11. Elekta 19.3.11.1. Overview 19.3.11.2. Product Portfolio 19.3.11.3. Key Financials 19.3.11.4. SWOT Analysis 19.3.11.5. Key Developments 19.3.11.6. Sales Footprint 19.3.11.7. Strategy Overview 19.3.11.7.1. Marketing Strategy 19.3.11.7.2. Product Strategy 19.3.11.7.3. Channel Strategy 19.3.12. Clarus Medical 19.3.12.1. Overview 19.3.12.2. Product Portfolio 19.3.12.3. Key Financials 19.3.12.4. SWOT Analysis 19.3.12.5. Key Developments 19.3.12.6. Sales Footprint 19.3.12.7. Strategy Overview 19.3.12.7.1. Marketing Strategy 19.3.12.7.2. Product Strategy 19.3.12.7.3. Channel Strategy 19.3.13. MACHIDA ENDOSCOPE CO., LTD. 19.3.13.1. Overview 19.3.13.2. Product Portfolio 19.3.13.3. Key Financials 19.3.13.4. SWOT Analysis 19.3.13.5. Key Developments 19.3.13.6. Sales Footprint 19.3.13.7. Strategy Overview 19.3.13.7.1. Marketing Strategy 19.3.13.7.2. Product Strategy 19.3.13.7.3. Channel Strategy 20. Assumptions and Acronyms Used 21. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Persistence Market Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD(demand)の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ(Persistence Market Research/PMR)は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |